ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies

Thomas R. Collins  |  April 1, 2013

Studies look at how the balance between osteoclast-mediated bone resorption and osteoblast mediated bone formation is undermined in people with arthritic conditions

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:ACR/ARHP Annual Meetingbone formationbone lossResearch

What Mick Jagger Can Teach Us About Growing Old Gracefully

Simon M. Helfgott, MD  |  February 1, 2013

Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:agingpatient carerheumatologistTreatment

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein  |  February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

Filed under:ConditionsMeeting ReportsResearch RheumSystemic Lupus Erythematosus Tagged with:comorbiditiesLupusResearchSLETreatment

When to Refer Rheumatology Patients to Physical Therapy

Alicia Lovato PT, DPT  |  January 1, 2013

Consider a physical therapist for your patients if they have difficulty adapting to a new disability, impaired range of motion or strength, a significant balance or gait disturbance, a history of falls, or mobility issues

Filed under:From the CollegePractice Support Tagged with:disabilitymobilitypatient carePhysical Therapy

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins  |  January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR/ARHP Annual Meetingbisphosphonatesbone lossOsteoporosisTreatment

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Ankylosing SpondylitisBiologicsBiosimilarsdrugFDAinfliximabJAK inhibitorsjanus kinaseMethotrexatePipelinePolymyalgia Rheumaticaprednisonepsoriatic arthritisRheumatoid arthritisSafetyTofacitinib

Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?

Reeti K. Joshi, MD, Richa Gupta, MD, Hyon Ju Park, MD, Christine Pham, MD, and Leslie Kahl, MD  |  October 1, 2012

Rheumatologists face the emerging picture of cocaine and levamisole-associated vasculopathy in clinical practice

Filed under:ConditionsVasculitis Tagged with:ANA titerANCA-Associated Vasculitispatient carerheumatologistVasculitisvasculopathy

American College of Rheumatology Award Provides Researchers Time for Career Development

Staff  |  September 5, 2012

The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.

Filed under:AwardsCareer DevelopmentEducation & TrainingFrom the CollegeMeeting ReportsProfessional TopicsResearch Rheum Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)AwardsResearchRheumatology Research Foundation

EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

Thomas R. Collins  |  August 8, 2012

Advances in the rheumatology clinic are promising, two experts say.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:BiologicsEULARHYDROXYCHLOROQUINEinfliximabInternationalMethotrexatepatient careRheumatoid arthritisrheumatologisttocilizumab

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 9, 2012

Information on new approvals and medication safety.

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing SpondylitisBiologicsbiophosphonatesdrugJAK inhibitorsjanus kinaseMethotrexateopioidPainRheumatoid arthritisrheumatologistrituximabSafetySystemic lupus erythematosustocilizumabTofacitinib

  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 65
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences